Capital Impact Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
CAM
Capital Impact Advisors's LMAT Position: Q3 2023 in Review
Capital Impact Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2023, closing a stake of 9,075 shares — an estimated $611K sold.
Capital Impact Advisors first reported a position in LMAT in Q1 2018 and held it in 22 quarters. The position peaked at $3.18M in Q1 2021. 220 funds tracked by Wall St. Rank hold LMAT as of Q3 2023.
- Capital Impact Advisors reported no remaining LeMaitre Vascular position as of Q3 2023 after selling out during the quarter.
- Capital Impact Advisors sold 9,075 LeMaitre Vascular shares in Q3 2023, an estimated $611K.
- Capital Impact Advisors first reported a position in LeMaitre Vascular in Q1 2018 and held it in 22 quarters.
- Capital Impact Advisors's LeMaitre Vascular position peaked at $3.18M in Q1 2021.
- 220 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2023.
Based on Capital Impact Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.